PTDSS2
Phosphatidylserine synthase 2
Also known as: PSS2, PTSS2_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9BVG9
- Gene
- PTDSS2
- Ensembl
- ENSG00000174915
- Chromosome
- 11
- Canonical length
- 487 aa
- Protein class
- Enzymes, Metabolic proteins, Predicted membrane proteins
OverviewNCBI Gene
The protein encoded by this gene catalyzes the conversion of phosphatidylethanolamine to phosphatidylserine, a structural membrane phospholipid that functions in cell signaling, blood coagulation, and apoptosis. The encoded enzyme also has a high affinity for docosahexaenoic acid (DHA) and can use it to make DHA-containing phosphatidylserine. [provided by RefSeq, Jul 2016]
Canonical amino-acid sequenceUniProt
487 residues, UniProt reviewed canonical sequence.
>Q9BVG9|PTDSS2
1 MRRGERRDAG GPRPESPVPA GRASLEEPPD GPSAGQATGP GEGRRSTESE VYDDGTNTFF
61 WRAHTLTVLF ILTCTLGYVT LLEETPQDTA YNTKRGIVAS ILVFLCFGVT QAKDGPFSRP
121 HPAYWRFWLC VSVVYELFLI FILFQTVQDG RQFLKYVDPK LGVPLPERDY GGNCLIYDPD
181 NETDPFHNIW DKLDGFVPAH FLGWYLKTLM IRDWWMCMII SVMFEFLEYS LEHQLPNFSE
241 CWWDHWIMDV LVCNGLGIYC GMKTLEWLSL KTYKWQGLWN IPTYKGKMKR IAFQFTPYSW
301 VRFEWKPASS LRRWLAVCGI ILVFLLAELN TFYLKFVLWM PPEHYLVLLR LVFFVNVGGV
361 AMREIYDFMD DPKPHKKLGP QAWLVAAITA TELLIVVKYD PHTLTLSLPF YISQCWTLGS
421 VLALTWTVWR FFLRDITLRY KETRWQKWQN KDDQGSTVGN GDQHPLGLDE DLLGPGVAEG
481 EGAPTPNLocalizationUniProt · AlphaFold · HPA
Whether an antibody against PTDSS2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Other membrane
- Secreted
- No
- Transmembrane segments
- 7
- Mean surface accessibility (rSASA)
- 0.38
- Highest tissue expression
- 45 nTPM
Expression across tissuesHPA
Tissue
- testis: 45 nTPM
- cerebellum: 24 nTPM
- heart muscle: 24 nTPM
- spinal cord: 24 nTPM
- ovary: 21 nTPM
- adrenal gland: 21 nTPM
Single-cell type
- late spermatids: 255 nCPM
- late primary spermatocytes: 80 nCPM
- early spermatids: 58 nCPM
- oligodendrocytes: 39 nCPM
- astrocytes: 36 nCPM
- early primary spermatocytes: 33 nCPM
Immune cell
- naive CD8 T-cell: 0.3 nTPM
- gdT-cell: 0.2 nTPM
- intermediate monocyte: 0.2 nTPM
- plasmacytoid DC: 0.2 nTPM
- classical monocyte: 0.1 nTPM
- memory CD8 T-cell: 0.1 nTPM
Brain region
- white matter: 32 nTPM
- medulla oblongata: 29 nTPM
- cerebral cortex: 28 nTPM
- basal ganglia: 27 nTPM
- midbrain: 26 nTPM
- cerebellum: 25 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.71
- gnomAD pLI
- 0
- gnomAD missense Z
- 1.57
- DepMap mean gene effect
- 0.04
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
- L-serine-phosphatidylethanolamine phosphatidyltransferase activity
- transferase activity
- CDP-diacylglycerol-serine O-phosphatidyltransferase activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of PTDSS2 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads PTDSS2 as an antibody target. Whether an autoantibody or antibody against PTDSS2 could matter depends on whether native PTDSS2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
PTDSS2 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label PTDSS2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...